环已基膦 | 822-68-4

• 分子结构分类: 有机化合物 - 有机磷化合物
• 中文名称: 环已基膦
• 中文别名: 环己基膦
• 英文名称: cyclohexylphosphine
• 英文别名: cyclohexylphosphane
• CAS: 822-68-4
• 化学式: C₆H₁₃P
• mdl: MFCD00014297
• 分子量: 116.143
• InChiKey: ZBCKWHYWPLHBOK-UHFFFAOYSA-N

物化性质

• 沸点：
  67-69°C
• 密度：
  0,875 g/cm3
• 闪点：
  -21°C

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 危险类别码：
  R17,R34,R20/21/22
• 危险品运输编号：
  UN 3185
• 安全说明：
  S16,S26,S36/37/39,S9

SDS

---

Section 1: Product Identification
Chemical Name: Cyclohexylphosphine, min. 97%(Sure Seal TM bottle)
CAS Registry Number: 822-68-4
Formula: C6H11PH2
EINECS Number: none
Chemical Family: organophosphorus ligand
Synonym: none

---

Section 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title Compound 822-68-4 100% no data no data

---

Section 3: Hazards Identification
Harmful by inhalation, in contact with skin and if swallowed. Material has a pungent odor. Inhalation of vapors
Emergency Overview:
may lead to headache and dizziness.
Primary Routes of Exposure: Ingestion, skin, inhalation
Eye Contact: May cause mild to severe irritation of the eyes.
Skin Contact: Harmful in contact with skin. May cause mild irritation of the skin, or thermal burns if ignited.
Harmful by inhalation. Inhalation may lead to headaches and dizziness. May be irritating to nose and mucous
Inhalation:
membranes.
Ingestion: Harmful if swallowed. May cause vomiting and diarrhea.
Acute Health Affects: Harmful by inhalation, in contact with skin and if swallowed.
Chronic Health Affects: No information available on long-term chronic effects.
NTP: No
IARC: No
OSHA: No

---

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

---

SECTION 5: Fire Fighting Measures
Flash Point: no data
Autoignition Temperature: pyrophoric
Explosion Limits: Pyrophoric
Extinguishing Medium: carbon dioxide, dry powder or foam
The pyrophoric liquid may reignite. Fire fighters should be equipped with an approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion and If involved in a fire this material may emit toxic organic fumes and vapors of phosphorus pentoxide.
Decomposion Products:
Unusual Fire or Explosion Hazards: Spontaneously flammable in air, especially in contact with organic matter such as paper or cloth.

---

SECTION 6: Accidental Release Measures
'The material may ignite spontaneously in air. Avoid static discharge. Burning material may release
toxic fumes. In case of poor ventilation, leave the area unless fitted with a self-contained breathing apparatus.
Spill and Leak Procedures:
Small spills can be mixed with ground limestone, sodium bicarbonate, or other suitable absorbents, swept up,
and held in a closed metal can.

---

SECTION 7: Handling and Storage
Store in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep away from heat.
Handling and Storage: Material should be transferred under an inert atmosphere of nitrogen or argon in a efficient fume hood. Fire
may occur in emptied container and transfer lines.

---

SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear protective clothing and gloves.
Ventilation: Material has a pungent odor. Always handle material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation: Material has a pungent odor. Always handle material in an efficient fume hood.
Additional Protection: Wear a full face shield, flame resistant lab apron and suitable gloves.

---

SECTION 9: Physical and Chemical Properties
Color and Form: colorless liq.
Molecular Weight: 116.14
Melting Point: no data
Boiling Point: 145°C
Vapor Pressure: no data
Specific Gravity: 0.8750
Odor: pungent, offensive odor
Solubility in Water: insoluble

---

SECTION 10: Stability and Reactivity
Stability: air-sensitive liquid - pyrophoric
Hazardous Polymerization: no hazardous polymerization
Contact with air. Material may spontaneously ignite, especially in the presence of organic matter such as
Conditions to Avoid:
paper or cloth.
Incompatibility: oxidizing agents, halogens, air (pyrophoric), halocarbons, sulfur.
Decomposition Products: carbon dioxide, carbon monoxide, organic vapors, and phosphorus pentoxide.

---

SECTION 11: Toxicological Information
RTECS Data: No information available in the RTECS files.
Carcinogenic Effects: No data available
Mutagenic Effects: No data available
Tetratogenic Effects: No data available

---

SECTION 12: Ecological Information
Ecological Information: No information available

---

SECTION 13: Disposal Considerations
Disposal: Dispose of according to local, state and federal regulations.

---

SECTION 14: Transportation
Shipping Name (CFR): Pyrophoric liquids, organic, N.O.S.
Hazard Class (CFR): 4.2
Additional Hazard Class (CFR): NA
Packaging Group (CFR): I
UN ID Number (CFR): UN# 2845
Shipping Name (IATA): Forbidden
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): UN# 2845

---

SECTION 15: Regulatory Information
TSCA: Not listed in the TSCA inventory.
SARA (Title 313): Not reportable under SARA Title 313
Second Ingredient: none

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  环已基膦 在 盐酸 作用下， 生成 Bis-<2-hydroxy-ethyl>-cyclohexyl-phosphin
  参考文献：
  名称：

  Tzschach,A. et al., Zeitschrift fur Chemie, 1979, vol. 19, p. 252 - 253

  摘要：

  DOI：
• 作为产物：
  描述：

  环己基膦酰二氯 在 sodium 、 甲苯 作用下， 生成 环已基膦
  参考文献：
  名称：

  Horner et al., Chemische Berichte, 1959, vol. 92, p. 2088,2093

  摘要：

  DOI：
• 作为试剂：
  描述：

  2,6-二氯烟酰胺 在 platinum(IV) oxide 、 tris-(dibenzylideneacetone)dipalladium(0) 、 氢气 、 caesium carbonate 、 环已基膦 作用下， 以 1,4-二氧六环 、 甲醇 、 水 为溶剂， 反应 38.0h， 生成 tert-butyl 3-(5-carbamoyl-6-(4-phenoxyphenyl)pyridin-2-yl)piperidine-1-carboxylate
  参考文献：
  名称：

  一种同时靶向BTK和GSPT1蛋白的降解剂

  摘要：

  本发明涉及式(I)所示的化合物、其药学上可接受的盐、对映体、立体异构体、溶剂化物、多晶型物或N‑氧化物：X‑L‑Y (I)其中，X为BTK结合基团，L为连接基团，Y为泛素连接酶结合基团。本发明化合物为既具有PROTAC分子的特点，同时能够以分子胶的方式发挥作用的降解剂，在多种肿瘤细胞中都可以同时降解BTK和GSPT1，并且高效地抑制肿瘤细胞的增殖、诱导肿瘤细胞凋亡。

  公开号：

  CN115304606A

文献信息

• Mild electrophilic trifluoromethylation of secondary and primary aryl- and alkylphosphines using hypervalent iodine(iii)–CF3 reagents
  作者：Patrick Eisenberger、Iris Kieltsch、Nicolas Armanino、Antonio Togni

  DOI：10.1039/b801424h

  日期：——

  A direct, mild and efficient trifluoromethylation of primary and secondary phosphines is achieved with easily accessible, cheap hypervalent iodine compounds acting as electrophilic CF(3)-transfer reagents.

  直接，温和和有效的伯，仲膦的三氟甲基化反应可以通过容易获得，便宜的高价碘化合物作为亲电CF（3）转移试剂来实现。
• Mononuclear iron complex and organic synthesis reaction using same
  申请人：KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION

  公开号：US10363551B2

  公开（公告）日：2019-07-30

  A mononuclear iron bivalent complex having iron-silicon bonds, which is represented by formula (1), can exhibit an excellent catalytic activity in at least one reaction selected from three reactions, i.e., a hydrosilylation reaction, a hydrogenation reaction and a reaction for reducing a carbonyl compound. (In the formula, R1 to R6 independently represent a hydrogen atom, an alkyl group which may be substituted by X, or the like; X represents a halogen atom, or the like; L1 represents at least one two-electron ligand selected from an isonitrile ligand, an amine ligand, an imine ligand, a nitrogenated heterocyclic ring, a phosphine ligand, a phosphite ligand and a sulfide ligand, wherein, when multiple L1's are present, two L1's may be bonded to each other; L2 represents a two-electron ligand that is different from a CO ligand or the above-mentioned L1, wherein, when multiple L2's are present, two L2's may be bonded to each other; and m1 represents an integer of 1 to 4 and m2 represents an integer of 0 to 3, wherein the sum total of m1 and m2 (i.e., m1+m2) satisfies 3 or 4.)

  具有铁-硅键的单核二价铁络合物，其由公式（1）表示，可以在三个反应中选择至少一个反应表现出优异的催化活性，即硅氢化反应、氢化反应和还原羰基化合物的反应。 （在公式中，R1至R6独立代表氢原子、可能被X取代的烷基团等；X代表卤素原子等；L1代表至少一种从异腈配体、胺配体、亚胺配体、氮杂环、膦配体、亚磷酸盐配体和硫化物配体中选择的两电子配体，其中，当存在多个L1时，两个L1可以相互连接；L2代表与CO配体或上述L1不同的两电子配体，其中，当存在多个L2时，两个L2可以相互连接；m1代表1至4的整数，m2代表0至3的整数，其中m1和m2的总和（即m1+m2）满足3或4。）
• NITROGENOUS-RING ACYLGUANIDINE DERIVATIVE
  申请人：Kinoyama Isao

  公开号：US20120142727A1

  公开（公告）日：2012-06-07

  [Object] An excellent agent for preventing or treating dementia, schizophrenia, and the like, based on serotonin 5-HT 5A receptor modulating action, is provided. [Means for Solution] It was confirmed that acylguanidine derivatives (the following formula I; any one of Z 1 , Z 2 , Z 3 , Z 4 and Z 5 is nitrogen atom, and the others are carbon atoms) which have the characteristic structure in which the guanidine is bonded to one ring of the quinoline or isoquinoline via a carbonyl group, and a cyclic group is bonded to the other ring, exhibit potent 5-HT 5A receptor modulating actions and excellent pharmacological actions based on the 5-HT 5A receptor modulating action, and thus can be excellent agents for preventing or treating dementia, schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder. Thus, the present invention has been completed.

  提供一个基于调节5-HT5A受体的作用，用于预防或治疗痴呆、精神分裂症等的优秀药剂。[解决方案]确认了酰脒衍生物（以下公式I；Z1、Z2、Z3、Z4和Z5中的任何一个为氮原子，其余为碳原子）具有特征性结构，其中脒基通过羰基与喹啉或异喹啉的一个环连接，并且另一个环连接有环状基团，展现出强大的5-HT5A受体调节作用和基于5-HT5A受体调节作用的优秀药理作用，因此可作为预防或治疗痴呆、精神分裂症、双相情感障碍或注意力缺陷多动障碍的优秀药剂。因此，完成了本发明。
• Synthesis and Identification of Aryl and Alkyl Gem-Dilithium Phosphido-Boranes: A Boost to the Chemistry of Phosphandiides
  作者：Jie Guang、Romain Duwald、Jacques Maddaluno、Hassan Oulyadi、Sami Lakhdar、Annie-Claude Gaumont、Anne Harrison-Marchand

  DOI：10.1002/chem.201800742

  日期：2018.5.7

  bi‐dimensional NMR analyses, indicates a strong influence of the phosphorus substituent on the structure of the gem‐dianionic phosphorus structure; a monomeric arrangement was obtained when R=phenyl, whereas a cyclic oligomer was observed for R=cyclohexyl. These compounds represent a new type of useful reagent, and their access paves the way for the concept of “RP synthons” (i.e., RP2− phosphandiides), likely

  合成和前所未有偕-二阴离子的磷化合物的识别，即，偕-二锂膦-硼烷锂2 [RP⋅BH 3 ]，其中R =苯基或CY，在THF溶液中的报道。这些由双去质子化得到相应的伯膦-硼烷的前体RPH 2 ⋅BH 3。他们基于多核（1 H，6 Li，7 Li，11 B，13 C，31P）一维和二维NMR分析表明磷取代基对宝石双阴离子磷结构的影响很大；当R ＝苯基时，获得了单体排列，而对于R ＝环己基，观察到环状低聚物。这些化合物代表了一种新型的有用试剂，它们的使用为“ RP合子”（即RP 2-磷杂化物）的概念铺平了道路，后者可能是各种磷靶标中最灵活的前体。
• COMPOUND COMPRISING PHENYL PYRIDINE UNITS
  申请人：Ye Qing

  公开号：US20090289547A1

  公开（公告）日：2009-11-26

  Organic compounds of formula I may be used in optoelectronic devices wherein R 1 is, independently at each occurrence, a C 1 -C 20 aliphatic radical, a C 3 -C 20 aromatic radical, or a C 3 -C 20 cycloaliphatic radical; R2 is, independently at each occurrence, a C 1 -C 20 aliphatic radical, a C 3 -C 20 aromatic radical, or a C 3 -C 20 cycloaliphatic radical; a is, independently at each occurrence, an integer ranging from 0-4; b is, independently at each occurrence, an integer ranging from 0-3; Ar 1 is a direct bond or heteroaryl, aryl, or alkyl or cycloalkyl; Ar 2 is heteroaryl, aryl, or alkyl or cycloalkyl; c is 0, 1 or 2; and n is an integer ranging from 2-4.

  化学式I的有机化合物可用于光电子器件，其中R1在每次出现时独立地是C1-C20脂肪基、C3-C20芳香基或C3-C20环脂肪基；R2在每次出现时独立地是C1-C20脂肪基、C3-C20芳香基或C3-C20环脂肪基；a在每次出现时独立地是0-4之间的整数；b在每次出现时独立地是0-3之间的整数；Ar1是直接键或杂环芳基、芳基、烷基或环烷基；Ar2是杂环芳基、芳基、烷基或环烷基；c为0、1或2；n是2-4之间的整数。